(2S,3R)-2-[(6-bromoisoquinolin-1-yl)amino]-N,3-bis[(2-methylpropan-2-yl)oxy]butanamide
C21H30BrN3O3 — CID 158550565
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3R)-2-[(6-bromoisoquinolin-1-yl)amino]-N,3-bis[(2-methylpropan-2-yl)oxy]butanamide
(2S,3R)-2-[(6-bromoisoquinolin-1-yl)amino]-N,3-bis[(2-methylpropan-2-yl)oxy]butanamide (PubChem CID 158550565) has the molecular formula C21H30BrN3O3 and a molecular weight of 452.39 g/mol. Its IUPAC name is (2S,3R)-2-[(6-bromoisoquinolin-1-yl)amino]-N,3-bis[(2-methylpropan-2-yl)oxy]butanamide.
Molecular Properties
| Compound Name | (2S,3R)-2-[(6-bromoisoquinolin-1-yl)amino]-N,3-bis[(2-methylpropan-2-yl)oxy]butanamide |
|---|---|
| PubChem CID | 158550565 |
| Molecular Formula | C21H30BrN3O3 |
| Molecular Weight | 452.39 g/mol |
| Exact Mass | 451.15 |
| IUPAC Name | (2S,3R)-2-[(6-bromoisoquinolin-1-yl)amino]-N,3-bis[(2-methylpropan-2-yl)oxy]butanamide |
| SMILES | C[C@@H](OC(C)(C)C)[C@H](Nc1nccc2cc(Br)ccc12)C(=O)NOC(C)(C)C |
| InChI | InChI=1S/C21H30BrN3O3/c1-13(27-20(2,3)4)17(19(26)25-28-21(5,6)7)24-18-16-9-8-15(22)12-14(16)10-11-23-18/h8-13,17H,1-7H3,(H,23,24)(H,25,26)/t13-,17+/m1/s1 |
| InChIKey | MIRNGDCMZKNVRO-DYVFJYSZSA-N |
| XLogP | 4.83 |
| TPSA | 72.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.39 |
| LogP ≤ 5 | 4.83 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158550565 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.